Brighthouse Financial, Inc. (BHF)
NASDAQ: BHF · Real-Time Price · USD
46.45
+0.31 (0.67%)
Aug 13, 2025, 9:49 AM - Market open

Revance Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts that cover Revance Therapeutics stock have a consensus rating of "Hold" and an average price target of $56.44, which forecasts a 21.51% increase in the stock price over the next year. The lowest target is $42 and the highest is $72.

Price Target: $56.44 (+21.51%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$42$56.44$55$72
Change-9.58%+21.51%+18.41%+55.01%

Analyst Ratings

The average analyst rating for Revance Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy111111
Buy111111
Hold666665
Sell122222
Strong Sell000000
Total9101010109

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Keefe, Bruyette & Woods
Keefe, Bruyette & Woods
Hold
Maintains
$57$50
HoldMaintains$57$50+7.64%Aug 11, 2025
Barclays
Barclays
Buy
Maintains
$70$65
BuyMaintains$70$65+39.94%Aug 8, 2025
Morgan Stanley
Morgan Stanley
Sell
Maintains
$45$42
SellMaintains$45$42-9.58%Jul 14, 2025
Wells Fargo
Wells Fargo
Hold
Maintains
$53$54
HoldMaintains$53$54+16.25%Jul 10, 2025
JP Morgan
JP Morgan
Sell
Maintains
$56$63
SellMaintains$56$63+35.63%Jul 8, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
8.93B
from 6.30B
Increased by 41.89%
Revenue Next Year
9.20B
from 8.93B
Increased by 2.98%
EPS This Year
18.96
from 4.64
Increased by 308.59%
EPS Next Year
21.90
from 18.96
Increased by 15.49%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
8.50B4.94B10.74B4.47B6.30B8.93B9.20B9.35B
Revenue Growth
30.34%-41.93%117.61%-58.34%40.70%41.89%2.98%1.60%
EPS
-11.5918.3951.30-18.394.6418.9621.9024.24
EPS Growth
--178.96%--308.59%15.49%10.72%
Forward PE
-----2.452.121.92
No. Analysts
-----11118
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025202620272028
High9.5B9.9B10.2B
Avg8.9B9.2B9.3B
Low8.5B8.6B8.6B

Revenue Growth

Revenue Growth2025202620272028
High
50.5%
11.2%
10.6%
Avg
41.9%
3.0%
1.6%
Low
35.3%
-3.3%
-6.3%

EPS Forecast

EPS2025202620272028
High20.5324.9627.83
Avg18.9621.9024.24
Low17.6119.6021.34

EPS Growth

EPS Growth2025202620272028
High
342.4%
31.6%
27.1%
Avg
308.6%
15.5%
10.7%
Low
279.5%
3.4%
-2.5%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.